The vaccine, developed by the University of
Oxford in the UK to prevent coronavirus, has been shown to be safe for the
human body and can boost immunity.
After testing on about 1,07 people, it was found that injections of this vaccine produce antibodies and white blood cells in their body, which can fight against coronavirus inside the body.
It is being described as a very promising discovery. However, it is not yet time to say whether it will be able to provide full protection. Extensive experiments are still going on.
The United Kingdom has already demanded 100 million ticks.
How does the vaccine work?
Work is underway at an unusually fast pace to create this vaccine called ChAdOx1 nCoV-19.
The vaccine is being developed by genetically modifying a
virus that makes the chimpanzee's body a common cold. It has been extensively
modified so that it does not create infections in the human body. It has also
been given a close resemblance to the coronavirus.
Scientists have inserted the genetic trait of the coronavirus spike protein (the part that attacks our cells) into the vaccine that is being developed.
This means that the vaccine becomes identical to the coronavirus and then the body's immune system understands how to attack and defeat the coronavirus.
What are antibodies and T-cells?
Much of the emphasis in coronavirus prevention is on antibodies, which are only a part of our body's immune system.
An antibody is a small protein made by the body's immune system, which sets in with the virus and tries to destroy it.
Antibodies can inactivate coronavirus.
T-cells, a white part of the blood, help the body's immune
system to detect and destroy infected cells.
Almost all effective vaccines work by strengthening the antibody and T-cell system.
The number of T-cells increases the most after 14 days of vaccination and the number of antibodies increases the most within 28 days. However, researchers have not yet been able to verify how long-term immunity can be.
Is it safe?
It is safe, but it also has some side effects.
Although they are not very dangerous. Eighty percent of those who took the test reported a fever or headache after receiving the vaccine.
Researchers say that it can be controlled by taking paracetamol.
Sarah Gilbert, a professor at the University of Oxford in the United Kingdom, said: However, the initial results are very promising.
What will happen in the next step of the test?
Although the results so far are promising enough, its main purpose is to ensure that it is safe to give to all people.
Studies have shown that it can protect people from illness or reduce their Covid-19 symptoms.
More than 10,000 people across the UK will take
part in the next phase of the test. However, this test will be done in other countries as well. Since the rate of coronavirus infection in the UK is now low, it is difficult to find out how effective the vaccine is. About 30,000 people are expected to be tested in the United States. At the same time, 2,000 people in South Africa and 5,000 people in Brazil will be tested.
The vaccine, developed by the University of Oxford in the UK to prevent coronavirus, has been shown to be safe for the human body and can boost immunity.
After testing on about 1,07 people, it was found that injections of this vaccine produce antibodies and white blood cells in their body, which can fight against coronavirus inside the body.
It is being described as a very promising discovery. However, it is not yet time to say whether it will be able to provide full protection. Extensive experiments are still going on.
The United Kingdom has already demanded 100 million ticks.
How does the vaccine work?
Work is underway at an unusually fast pace to create this vaccine called ChAdOx1 nCoV-19.
The vaccine is being developed by genetically modifying a
virus that makes the chimpanzee's body a common cold. It has been extensively
modified so that it does not create infections in the human body. It has also
been given a close resemblance to the coronavirus.
Scientists have inserted the genetic trait of the coronavirus spike protein (the part that attacks our cells) into the vaccine that is being developed.
This means that the vaccine becomes identical to the coronavirus and then the body's immune system understands how to attack and defeat the coronavirus.
What are antibodies and T-cells?
Much of the emphasis in coronavirus prevention is on antibodies, which are only a part of our body's immune system.
An antibody is a small protein made by the body's immune system, which sets in with the virus and tries to destroy it.
Antibodies can inactivate coronavirus.
T-cells, a white part of the blood, help the body's immune
system to detect and destroy infected cells.
Almost all effective vaccines work by strengthening the antibody and T-cell system.
The number of T-cells increases the most after 14 days of vaccination and the number of antibodies increases the most within 28 days. However, researchers have not yet been able to verify how long-term immunity can be.
Is it safe?
It is safe, but it also has some side effects.
Although they are not very dangerous. Eighty percent of those who took the test reported a fever or headache after receiving the vaccine.
Researchers say that it can be controlled by taking paracetamol.
Sarah Gilbert, a professor at the University of Oxford in the United Kingdom, said: However, the initial results are very promising.
What will happen in the next step of the test?
Although the results so far are promising enough, its main purpose is to ensure that it is safe to give to all people.
Studies have shown that it can protect people from illness or reduce their Covid-19 symptoms.
More than 10,000 people across the UK will take
part in the next phase of the test. However, this test will be done in other countries as well. Since the rate of coronavirus infection in the UK is now low, it is difficult to find out how effective the vaccine is. About 30,000 people are expected to be tested in the United States. At the same time, 2,000 people in South Africa and 5,000 people in Brazil will be tested.
No comments:
Post a Comment